ISGlobal | Barcelona Institute for GlobalHealth




Over the past 15 years, 57 countries have succeeded in reducing the number of malaria cases by at least 75%, and 2015 was the first year in history that no indigenous cases were recorded in Europe. Despite these unprecedented achievements, there are still about 214 million cases of malaria every year and some 438,000 deaths, most of which occur in sub-Saharan Africa and affect the two most vulnerable population groups: children and pregnant women. Much work remains to be done, but the progress made in recent years has allowed us once again to envisage a more ambitious goal: a shift in focus from controlling malaria to eliminating the disease completely.

The importance of accelerating elimination efforts is underscored by two developments: the emergence of resistance to artemisinin in Southeast Asia and the growing number of mosquitoes of the genus Anopheles that have become resistant to the main insecticides used to control the vector population. In ISGlobal we strongly believe that the only long-term and sustainable solution is the complete elimination of the parasite from a given region, and through our Malaria Elimination Initiative we focus all our research, training and knowledge translation efforts on achieving this goal.

Main Lines of Research

  • Enabling technologies for malaria research
  • Parasite biology
  • Pathophysiology
  • Malaria immunology
  • Diagnostics
  • Evaluation of preventive and therapeutic tools
  • Epidemiology and clinical presentation of Plasmodium falciparum and Plasmodium vivax
  • Vector biology and control
  • Novel approaches and strategies for malaria elimination

Highlighted Projects

Past projects